Related Experiment Video
Updated: Dec 11, 2025

Assaying the Kinase Activity of LRRK2 in vitro
Published on: January 18, 2012
Structure of LRRK2 in Parkinson's disease and model for microtubule interaction
C K Deniston1,2, J Salogiannis1,3, S Mathea4
1Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA, USA.
Abstract:
Leucine-rich repeat kinase 2 (LRRK2) is the most commonly mutated gene in familial Parkinson's disease1 and is also linked to its idiopathic form2. LRRK2 has been proposed to function in membrane trafficking3 and colocalizes with microtubules4. Despite the fundamental importance of LRRK2 for understanding and treating Parkinson's disease, structural information on the enzyme is limited. Here we report the structure of the catalytic half of LRRK2, and an atomic model of microtubule-associated LRRK2 built using a reported cryo-electron tomography in situ structure5. We propose that the conformation of the LRRK2 kinase domain regulates its interactions with microtubules, with a closed conformation favouring oligomerization on microtubules. We show that the catalytic half of LRRK2 is sufficient for filament formation and blocks the motility of the microtubule-based motors kinesin 1 and cytoplasmic dynein 1 in vitro. Kinase inhibitors that stabilize an open conformation relieve this interference and reduce the formation of LRRK2 filaments in cells, whereas inhibitors that stabilize a closed conformation do not. Our findings suggest that LRRK2 can act as a roadblock for microtubule-based motors and have implications for the design of therapeutic LRRK2 kinase inhibitors.
Insights
Leucine-rich repeat kinase 2 (LRRK2) filaments can block motor protein movement on microtubules. Inhibitors stabilizing an open LRRK2 conformation reduce filament formation, offering a therapeutic strategy for Parkinson's disease.
Area of Science:
- Neuroscience
- Structural Biology
- Molecular Biology
Background:
- Leucine-rich repeat kinase 2 (LRRK2) is a key gene in Parkinson's disease pathogenesis.
- LRRK2's role in membrane trafficking and microtubule association is established.
- Limited structural data hinders understanding of LRRK2 function.
Purpose of the Study:
- To determine the structure of the catalytic half of LRRK2.
- To model microtubule-associated LRRK2.
- To elucidate the mechanism of LRRK2-microtubule interaction and its regulation by kinase conformation.
Main Methods:
- X-ray crystallography or cryo-EM for structural determination.
- Cryo-electron tomography for in situ structural modeling.
- In vitro motility assays with purified motors and LRRK2.
- Cell-based assays to assess LRRK2 filament formation and inhibitor effects.
Main Results:
- Reported the structure of the catalytic half of LRRK2.
- Developed an atomic model of microtubule-associated LRRK2.
- Demonstrated that LRRK2 filaments block kinesin-1 and dynein-1 motility.
- Showed that kinase inhibitors stabilizing an open conformation reduce LRRK2 filament formation in cells.
Conclusions:
- LRRK2 conformation regulates its microtubule association and oligomerization.
- LRRK2 can function as a physical roadblock for microtubule-based motors.
- Therapeutic strategies targeting LRRK2 conformation may be beneficial for Parkinson's disease.
Related Concept Videos
Lysosomal Hydrolases
Assembly of Complex Microtubule Structures
Microtubule Formation
Microtubule Associated Proteins (MAPs)
Destabilization of Microtubules
Parkinson's Disease: Overview

